echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Gut: Colon and rectal cancer survival rates in high-income countries

    Gut: Colon and rectal cancer survival rates in high-income countries

    • Last Update: 2020-06-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In a recent study published in Gut, an authoritative journal on digestive diseases, researchers aim to provide the latest estimates of the survival rates of colon and rectal cancer patients in seven high-income countries based on age and diagnostic stages as part of the International Partnership for the Evaluation of Cancer Benchmarking (ICBP) SURVMARK-2 projectresearchers analyzed data on 386,870 patients diagnosed in 19 cancer registry centres in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway and the United Kingdom) between 2010 and 2014Net survival rates for colon and rectal cancer patients were assessed for 1 and 5 years based on diagnostic phases, age and countrycolon and rectal cancer (1 year) and 5 years of net survival rates were between 59.1% and 70.9% (77.1% to 87.5%) and (84.8 to 90.0%) between 61.6% and 70.9%In Australia, Canada and Norway, patient survival rates have been high, and in Canada and Australia, the proportion of patients with metastatic diseases is smallerThe international differences in survival rates for regional and distant colon cancer patients (1 year) and 5 years were most pronounced, ranging from 62.5 to 77.5 per cent (86.0 to 94.1 per cent) and 8.0 to 17.3 per cent (40.7 to 56.4 per cent)Similar results were observed for rectal cancerThe staging distribution of colon and rectal cancer varies from country to country, and the survival rate of patients with older diseases and diagnosis (regardless of staging) varies significantlyIn some high-income countries, differences in survival for colon and rectal cancer patients may be due to early diagnosis, differences in the treatment of regional and distant diseases, and older age at the time of diagnosis in some countriesDifferences in cancer registration practices and different staging systems may affect comparisons
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.